Anti-YIF1B monoclonal antibody

Pre-made anti-YIF1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to YIF1B/YIF1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2287-Ab-1/ GM-Tg-hg-IP2287-Ab-2Anti-Human YIF1B monoclonal antibodyHuman
GM-Tg-rg-IP2287-Ab-1/ GM-Tg-rg-IP2287-Ab-2Anti-Rat YIF1B monoclonal antibodyRat
GM-Tg-mg-IP2287-Ab-1/ GM-Tg-mg-IP2287-Ab-2Anti-Mouse YIF1B monoclonal antibodyMouse
GM-Tg-cynog-IP2287-Ab-1/ GM-Tg-cynog-IP2287-Ab-2Anti-Cynomolgus/ Rhesus macaque YIF1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2287-Ab-1/ GM-Tg-felg-IP2287-Ab-2Anti-Feline YIF1B monoclonal antibodyFeline
GM-Tg-cang-IP2287-Ab-1/ GM-Tg-cang-IP2287-Ab-2Anti-Canine YIF1B monoclonal antibodyCanine
GM-Tg-bovg-IP2287-Ab-1/ GM-Tg-bovg-IP2287-Ab-2Anti-Bovine YIF1B monoclonal antibodyBovine
GM-Tg-equg-IP2287-Ab-1/ GM-Tg-equg-IP2287-Ab-2Anti-Equine YIF1B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2287-Ab-1/ GM-Tg-hg-IP2287-Ab-2; GM-Tg-rg-IP2287-Ab-1/ GM-Tg-rg-IP2287-Ab-2;
GM-Tg-mg-IP2287-Ab-1/ GM-Tg-mg-IP2287-Ab-2; GM-Tg-cynog-IP2287-Ab-1/ GM-Tg-cynog-IP2287-Ab-2;
GM-Tg-felg-IP2287-Ab-1/ GM-Tg-felg-IP2287-Ab-2; GM-Tg-cang-IP2287-Ab-1/ GM-Tg-cang-IP2287-Ab-2;
GM-Tg-bovg-IP2287-Ab-1/ GM-Tg-bovg-IP2287-Ab-2; GM-Tg-equg-IP2287-Ab-1/ GM-Tg-equg-IP2287-Ab-2
Products NameAnti-YIF1B monoclonal antibody
Formatmab
Target NameYIF1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-YIF1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2287-Ag-1Recombinant multi-species YIF1B/ FinGER8 protein


    Target information

    Target IDGM-IP2287
    Target NameYIF1B
    Gene ID90522,77254,292768,719551,484532,101096190,617320,100052293
    Gene Symbol and Synonyms9430029K10Rik,FinGER8,KABAMAS,YIF1B,Yip1b
    Uniprot AccessionQ5BJH7,Q6PEC3
    Uniprot Entry NameYIF1B_HUMAN,YIF1B_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167645
    Target ClassificationN/A

    The target: YIF1B, gene name: YIF1B, also named as FinGER8. Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport; protein targeting to membrane; and sperm axoneme assembly. Located in Golgi apparatus; endoplasmic reticulum; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.